Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Silverback Therapeutics Inc
(NQ:
SBTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 8, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silverback Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
LAWSUITS FILED AGAINST RECAF, ONTF and SBTX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
November 10, 2021
NEW YORK, NY / ACCESSWIRE / November 10, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...
From
Jakubowitz Law
Via
AccessWire
Topics
Fraud
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
SHAREHOLDER ALERT: Robbins LLP Informs Investors that Silverback Therapeutics, Inc. (SBTX) is Being Sued for Misleading Investors
November 09, 2021
From
Robbins LLP
Via
Business Wire
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EAR, TMC and SBTX
November 09, 2021
NEW YORK, NY / ACCESSWIRE / November 9, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....
From
The Gross Law Firm
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 09, 2021
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ALERT: HNST ONTF SBTX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
November 09, 2021
NEW YORK, NY / ACCESSWIRE / November 9, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...
From
The Law Offices of Vincent Wong
Via
AccessWire
Topics
Fraud
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZEV, RECAF and SBTX
November 09, 2021
NEW YORK, NY / ACCESSWIRE / November 9, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Silverback Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SBTX
November 09, 2021
From
Rosen Law Firm
Via
Business Wire
CLASS ACTION UPDATE for FB, ONTF and SBTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
November 09, 2021
NEW YORK, NY / ACCESSWIRE / November 9, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
SBTX ALERT: Silverback Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 08, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
SHAREHOLDER ALERT: TMC ONTF SBTX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
November 08, 2021
NEW YORK, NY / ACCESSWIRE / November 8, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...
From
The Law Offices of Vincent Wong
Via
AccessWire
Topics
Fraud
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 15, 2021
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market session. The company's market cap stands at $20.8...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 05, 2021
Gainers Synaptogenix (NASDAQ:SNPX) stock...
Via
Benzinga
Silverback Therapeutics to Participate in the H.C. Wainwright Hepatitis B Virus (HBV) Conference
October 05, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
44 Biggest Movers From Yesterday
October 05, 2021
Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 04, 2021
Gainers Progenity (NASDAQ:PROG) stock moved upwards by 18.43% to $2.12 during Monday's regular session. Trading volume for this security as of 12:30 EST is 91.5...
Via
Benzinga
30 Stocks Moving In Monday's Mid-Day Session
October 04, 2021
Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume...
Via
Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...
Via
Benzinga
Silverback Therapeutics, Inc. (NASDAQ:SBTX) Investor Notice: Investigation over Potential Violations of Securities Laws
September 27, 2021
San Diego, CA -- (SBWIRE) -- 09/27/2021 -- Silverback Therapeutics, Inc is under investigation over possible securities laws violations in connection with certain financial statements.
Via
SBWire
56 Biggest Movers From Yesterday
September 17, 2021
Check out these big penny stock gainers and losers Losers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48. MacroGenics, Inc. (NASDAQ...
Via
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
Mid-Afternoon Market Update: Dow Falls 70 Points; Aerie Pharmaceuticals Shares Plunge
September 16, 2021
Toward the end of trading Thursday, the Dow traded down 0.20% to 34,745 while the NASDAQ fell 0.03% to 15,157.61. The S&P also fell, dropping 0.21% to 4,471.34. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...
Via
Benzinga
Mid-Day Market Update: Gold Drops Over 2%; Leap Therapeutics Shares Jump
September 16, 2021
Midway through trading Thursday, the Dow traded down 0.74% to 34,557.75 while the NASDAQ fell 0.67% to 15,060.25. The S&P also fell, dropping 0.79% to 4,445.34. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.